Page last updated: 2024-12-07

1-adamantaneacetic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

## 1-Adamantaneacetic Acid: A Unique Molecule with Potential

1-Adamantaneacetic acid is a synthetic organic compound with a unique structure. It consists of an adamantane core, a rigid tricyclic hydrocarbon, attached to an acetic acid group. This unique structure grants it interesting properties that make it relevant for research in various fields.

**Here are some key features of 1-adamantaneacetic acid and its importance:**

* **Pharmacological Activity:** It has shown promising activity in various pharmacological studies, particularly in the fields of **anti-inflammatory, analgesic, and anticonvulsant effects**.
* **Anti-inflammatory:** Studies have shown its effectiveness in reducing inflammation in animal models.
* **Analgesic:** 1-adamantaneacetic acid demonstrates potential as a pain reliever, showing efficacy in animal models of chronic pain.
* **Anticonvulsant:** Research suggests its potential in treating epileptic seizures, though further investigation is needed.

* **Structural Features:** The rigid adamantane core provides a stable platform for drug development, allowing for modifications and derivatization to fine-tune its pharmacological activity and improve its pharmacokinetic properties.

* **Versatility in Research:** Its unique structure and potential pharmacological activity have made it a valuable tool in various research areas:
* **Drug Discovery:** 1-adamantaneacetic acid serves as a starting point for developing novel drugs with therapeutic potential.
* **Medicinal Chemistry:** Understanding its interactions with biological targets can lead to the development of new drugs for treating various conditions.
* **Biochemistry:** Studying its interactions with enzymes and receptors helps elucidate fundamental biological processes.

**However, it's important to note that:**

* **Limited Human Studies:** Currently, there is limited human data on the safety and efficacy of 1-adamantaneacetic acid. Further research is needed to explore its potential for therapeutic use in humans.
* **Potential Side Effects:** As with any drug, 1-adamantaneacetic acid may have potential side effects. More research is required to understand its safety profile in humans.

**Overall, 1-adamantaneacetic acid is a promising molecule with various potential applications in medicine and research. Its unique structure and pharmacological activity make it a valuable tool for developing new drugs and understanding biological processes. Further research is necessary to fully evaluate its potential benefits and risks.**

Cross-References

ID SourceID
PubMed CID123221
CHEMBL ID445874
SCHEMBL ID306081
SCHEMBL ID22604760
SCHEMBL ID24688608
MeSH IDM0494692

Synonyms (56)

Synonym
adamantaneacetate (aac)
bdbm36210
adamantan-1-ylacetic acid
tricyclo[3.3.1.1(3,7)-]decane-1-acetic acid
1-adamantaneacetic acid
1-adamantylacetic acid
tricyclo[3.3.1.13,7]decane-1-acetic acid
nsc310162
nsc-310162
4942-47-6
OPREA1_744522
1-adamantaneacetic acid, 98%
MAYBRIDGE1_002200
STK385038
tricyclo[3.3.1.1~3,7~]dec-1-ylacetic acid
A0736
1-carboxymethyladamantane
AKOS000264925
HMS547L22
2-(1-adamantyl)acetic acid
adamantan-1-yl-acetic acid
F1928-0005
CHEMBL445874
1-adamantaneacetate
2-(adamantan-1-yl)acetic acid
BBL010350
1-(carboxymethyl)adamantane
tricyclo[3.3.1.13,7]dec-1-ylacetic acid
AKOS016015543
GEO-00049
einecs 225-585-1
tricyclo(3.3.1.13,7)dec-1-ylacetic acid
nsc 310162
FT-0607298
SCHEMBL306081
mfcd00074728
SY012758
adamantyl acetic acid
1-adamantane acetic acid
(adamantan-1-yl)acetic acid
alpha-(1-adamantyl)acetic acid
1-adamantyl-acetic acid
alpha-(1-adamantyl)-acetic acid
1-adamantyl acetic acid
2-(adamant-1-yl)acetic acid
W-106023
DTXSID90197791
CS-W001578
F15428
AS-47688
AS-11645
EN300-00083
A905516
SCHEMBL22604760
SCHEMBL24688608
Z56757305
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID346025Binding affinity to beta cyclodextrin2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Convenient QSAR model for predicting the complexation of structurally diverse compounds with beta-cyclodextrins.
AID681133TP_TRANSPORTER: inhibition of lactate uptake in Xenopus laevis oocytes1999The Biochemical journal, Aug-01, Volume: 341 ( Pt 3)Characterization of the high-affinity monocarboxylate transporter MCT2 in Xenopus laevis oocytes.
AID681123TP_TRANSPORTER: inhibition of lactate uptake in Xenopus laevis oocytes1999The Biochemical journal, Aug-01, Volume: 341 ( Pt 3)Characterization of the high-affinity monocarboxylate transporter MCT2 in Xenopus laevis oocytes.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's5 (55.56)29.6817
2010's2 (22.22)24.3611
2020's1 (11.11)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.93

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.93 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.93 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.93)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]